β¨ Medicines Consent Notices
NEW ZEALAND GAZETTE, No. 62 β 4 JUNE 2015
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Nicabate Lozenge
Nicotine polacrilex 20mg equivalent to Nicotine 4mg
Lozenge
GlaxoSmithKline (NZ) Limited
GlaxoSmithKline Consumer Healthcare LP, South Carolina, United States of America
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Zoledronic Acid
Zoledronic acid monohydrate 0.8528mg/mL equivalent to Zoledronic acid 0.8 mg/mL
Concentrate for infusion
InterPharma (NZ) Limited
Lisapharma SpA, Erba, Italy
Dated this 29th day of May 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go3263
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Sandostatin LAR
Octreotide acetate 11.2mg equivalent to Octreotide 10mg
Powder for injection with diluent
Novartis New Zealand Limited
Sandoz GmbH, Tyrol, Austria
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Sandostatin LAR
Octreotide acetate 22.4mg equivalent to Octreotide 20mg
Powder for injection with diluent
Novartis New Zealand Limited
Sandoz GmbH, Tyrol, Austria
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Sandostatin LAR
Octreotide acetate 33.6mg equivalent to Octreotide 30mg
Powder for injection with diluent
Novartis New Zealand Limited
Sandoz GmbH, Tyrol, Austria
Dated this 29th day of May 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go3264
Renewal of Provisional Consent to the Distribution of a Medicine
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
54
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare29 May 2015
Medicines, Consent, Distribution, Nicabate, Zoledronic Acid
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare29 May 2015
Medicines, Consent, Distribution, Sandostatin LAR
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Renewal of Provisional Consent to the Distribution of a Medicine
π₯ Health & Social Welfare29 May 2015
Medicines, Renewal, Provisional Consent
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2015, No 62